Cargando…
Astragaloside IV alleviates the symptoms of experimental ulcerative colitis in vitro and in vivo
Ulcerative colitis (UC) is a chronic and relapsing inflammatory intestinal disease. Although the morbidity of UC has increased notably in recent years, effective therapeutic treatment remains unsatisfactory. Astragaloside IV (ASI), a monomeric compound isolated from the traditional Chinese medicine...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755457/ https://www.ncbi.nlm.nih.gov/pubmed/31572532 http://dx.doi.org/10.3892/etm.2019.7907 |